)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
DiaMedica Therapeutics
DiaMedica Therapeutics (DMAC) investor relations material
DiaMedica Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary1 Apr, 2026
Executive summary
Annual General Meeting scheduled for May 20, 2026, at the company’s Minneapolis headquarters.
Shareholders are invited to vote on key proposals, including director elections and executive compensation.
Voting matters and shareholder proposals
Election of seven directors to serve until the next Annual General Meeting or until successors are elected.
Ratification of Baker Tilly US, LLP as independent auditor for the fiscal year ending December 31, 2026.
Advisory (non-binding) vote to approve executive compensation.
Approval of amendment and restatement of the 2019 Omnibus Incentive Plan.
Other business may be transacted as properly brought before the meeting.
Board of directors and corporate governance
Seven nominees for director positions: Michael Giuffre, Richard Kuntz, Tanya N. Lewis, Daniel J. O'Connor, James Parsons, Rick Pauls, and Charles Semba.
Board recommends voting in favor of all director nominees.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from DiaMedica Therapeutics
- 2026 meeting seeks approval for director elections, auditor, executive pay, and expanded equity plan.DMAC
Proxy filing1 Apr 2026 - DM199 advanced in key trials with strong safety, efficacy, and a cash runway through 2H 2027.DMACQ4 202531 Mar 2026
- DM199 shows promise as a first-in-class therapy for preeclampsia and stroke, with strong clinical and financial backing.DMACCorporate presentation16 Mar 2026
- DM199 enters Phase II for preeclampsia, aiming for rapid, capital-efficient proof of concept.DMACStatus Update3 Feb 2026
- R&D spending rose, $54.1M cash supports DM199 trials, cash runway extended to Q3 2026.DMACQ2 20242 Feb 2026
- Net loss rose to $16.5M as R&D for DM199 increased, with cash runway through Q3 2026.DMACQ3 202414 Jan 2026
- Clinical trials advanced, net loss $24.4M, and cash runway extends into Q3 2026.DMACQ4 202426 Dec 2025
- Registering resale of 4.72M shares from a $11.8M private placement to fund clinical trials.DMACRegistration Filing16 Dec 2025
- Registration enables resale of 8.6M shares from a $30.1M private placement for DM199 development.DMACRegistration Filing16 Dec 2025
Next DiaMedica Therapeutics earnings date
Q1 202613 May, 2026
DiaMedica Therapeutics
Next DiaMedica Therapeutics earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage